Therapeutic Plasma Exchange Systems Market

Therapeutic Plasma Exchange Systems Market Size Share Insights 2023-2030

The therapeutic plasma exchange systems market witnessed significant demand during the pandemic period. The post-pandemic future also presents robust growth prospects with the increasing prevalence of conditions and adoption across healthcare settings. The therapeutic plasma exchange systems market study provides insights and forecasts across disease types including neurological disorders, cardiovascular disorders, hematology disorders, renal disorders, and others. Further, the market size forecast for Apheresis Machine, Filters, and others is provided from 2021 to 2030. The market across applications including Hospitals, Ambulatory Surgical Centers, and others forecast at the global and regional levels. Further, the country-wise outlook for over 25 countries is also provided in the industry analysis.

Therapeutic Plasma Exchange Systems Market Study Highlights, 2023

• The global Therapeutic Plasma Exchange Systems Market Size stood at US$1,490 Million in 2022 and is poised to register 8.54% growth over the forecast period from 2023 to 2030
• Neurological Disorders are the largest application types of Therapeutic Plasma Exchange Systems with a 40% market share. Other key types of conditions using therapeutic plasma exchange systems that are analyzed in the report include cardiovascular disorders, hematology disorders, renal disorders, and others.   
• Among product types, apheresis machines, filters, and others are analyzed in the research study. Of these, the machines account for the highest market share, in value terms.
• Of the different end users procuring therapeutic plasma exchange systems, hospitals own more than three-fourths of the market share, followed by ambulatory surgical centers, and others
• Driven by rapid adoption across end-user industries, and well-established healthcare infrastructure, North America dominates the global Therapeutic Plasma Exchange Systems market with the largest market share in value terms.
• Key market driving forces include- Chronic diseases and conditions are on the rise, Technological advancements in TPE systems, the Use of therapeutic plasma procedures in pediatric applications, the Increasing geriatric population, Focus on emerging countries as a major marketing strategy for expansion, and Increasing global healthcare expenditure worldwide, and others are identified among main market dynamics
• On the other hand, challenges associated with limited skilled professionals observed in developing countries, and high costs involved in the procurement of devices restrict the market growth
• The market is relatively concentrated in nature with intense competitive conditions among leading market players. Intense competitive conditions exist among large players, resulting in increased mergers and acquisitions activities.

Therapeutic Plasma Exchange Systems Market Outlook to 2030

Therapeutic Plasma Exchange Systems Market Overview

The therapeutic plasma market is rapidly emerging with the growing prevalence of chronic conditions across the world. Further, technological advancements in medical devices are encouraging wide adoption across hospitals and clinical settings.

Increased preference for use in the treatment of diverse chronic conditions is encouraging market growth for Therapeutic Plasma Exchange Systems across developed and developing countries. Most manufacturing companies are focusing on launching low-cost Therapeutic Plasma Exchange Systems to cater to strong demand growth from emerging markets.

The therapeutic plasma exchange procedures involve the passage of the patient’s blood through the apheresis machine and using filters, the plasma is removed with reinfusion of red blood cells along with replacement fluid such as plasma or albumin into the patient.

During the COVID-19 pandemic period, the plasma exchange procedure was used for the treatment of the infection in adults with severe COVID-19. In August 2020, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19. However, plasma therapy proved ineffective in halting Covid-19, and the usage widely fluctuated.

On the other hand, the high costs of medical equipment, therapeutic plasma exchange procedure, the dearth of skilled professionals, and the growing rental market will pose challenges to market growth.

Therapeutic Plasma Exchange Systems Market Trend - Technological advancements in TPE systems

High-precision technologies such as continuous-flow centrifugation technology can efficiently separate selected blood constituents such as plasma, leukocytes, platelets, or cells.

Technological advancements including the development of next-generation apheresis devices, equipped with screen navigation, GUI (graphical user interface) displays, automated interface, and other advancements are observed across systems. Advanced TPE systems minimize human intervention and improve the efficiencies of the procedure.

Further, technological advancements encourage the adoption of the systems across a wide range of conditions. Improved comfort and safety profile during the exchange procedure, improved balance control, and other benefits offered by new generation systems drive the penetration of systems.

Therapeutic Plasma Exchange Systems Market Opportunities- Use of therapeutic plasma procedure in pediatric applications

The therapeutic plasma exchange (TPE) treatment involving the removal of pathogenic materials in diverse neurologic, hematologic, renal, and autoimmune diseases in children is widely being assessed.

Currently, the penetration among the pediatric population is limited and the use is mostly based on retrospective, single-center experiences. Treatment of autoimmune diseases, Guillain-Barré syndrome (GBS), renal diseases, atherosclerosis, and other conditions are supporting the market growth.

Technological advancements and successful clinical trials on pediatric patients are encouraging adoption in children. During the COVID-19 pandemic, an increased number of procedures in pediatric patients were observed.

Therapeutic Plasma Exchange Systems Market Share Analysis- Neurological Disorders offer strong growth potential

Plasma exchange in patients with neurological disorders is predominantly associated with presumed aberrant humoral immune responses, including myasthenia gravis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and others.

Guillain-Barré syndrome (GBS)

It is a rare condition in which the peripheral nerves are inflamed, resulting in paralysis and sensory disturbance. Guillain-Barré syndrome includes acute inflammatory demyelinating polyradiculoneuropathy, acute motor axonal neuropathy, acute motor and sensory axonal neuropathy, Miller Fisher syndrome, and acute pandysautonomia.  The plasma exchange procedure is used to remove soluble factors including antibodies from the blood and replaces them with an artificial substitute such as an albumin solution.

Chronic inflammatory demyelinating polyneuropathy

Chronic inflammatory demyelinating polyneuropathy is a progressive or relapsing paralyzing disease caused by inflammation of the peripheral nerves. The rare type of autoimmune disorder is treated using immunomodulators. Alternatively, the plasmapheresis procedure involves blood removal and separating the components that cause CIDP from the plasma.

Myasthenia gravis

Patients with Myasthenia gravis (MG) are treated with therapeutic plasma exchange (TPE) wherein the plasma containing harmful antibodies is replaced with disease-free replacement fluid.

Multiple sclerosis

Multiple sclerosis is a chronic disease that affects the central nervous system. Different types of conditions such as clinically isolated syndrome, Relapse-remitting MS, Primary progressive MS, and Secondary progressive MS are observed in the patients.

PANDAS

PANDAS is short for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. Therapeutic plasma apheresis is used for the reversal of PANDAS treatment in children and adolescents.

Therapeutic Plasma Exchange Systems Market Segmentation

Disease

• Neurological Disorders
• Cardiovascular Disorders
• Hematology Disorders
• Renal Disorders
• Others

Product

• Apheresis Machine
• Filters
• Others

Applications

• Hospitals
• Ambulatory Surgical Centers
• Others

Regions

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Companies

• Baxter International Inc.
• Terumo Corporation
• Asahi Kasei Corp.
• B. Braun Melsngen AG
• Fresenius-Kabi AG
• Cerus Corp
• Hemacare Corp
• Terumo Corp
• Kawasumi Laboratories
• Haemonetics Corp

1. Executive Summary

1.1 Introduction to Therapeutic Plasma Exchange Systems Markets

1.2 Therapeutic Plasma Exchange Systems Market Size Outlook, 2021- 2030

1.3 Growth Opportunities in the Therapeutic Plasma Exchange Systems Industry

1.4 Winning Strategies for the post-pandemic future

 

2. Report Guide

2.1 Market Definition and Scope

2.2 Market Segmentation

2.3 Research Methodology

2.4 Forecast Methodology

2.5 List of Abbreviations

 

3. Growth Opportunity Analysis

3.1 Key Therapeutic Plasma Exchange Systems Market Trends

3.1.1 Chronic conditions are on the rise

3.1.2 Technological advancements in TPE systems

3.1.3 Use of therapeutic plasma procedure in pediatric applications

 

3.2 Key Therapeutic Plasma Exchange Systems Market Growth Drivers

3.2.1 Increasing geriatric population

3.2.2 Rapid adoption in hospitals

 

3.3 Key Therapeutic Plasma Exchange Systems Market Growth Restraints

3.3.1 Complexity of the procedure

3.3.2 High costs involved in the procurement of devices

 

4 Therapeutic Plasma Exchange Systems Market Outlook – Scenario Analysis

4.1 Low Growth Case Scenario Forecasts: Therapeutic Plasma Exchange Systems Market Size Outlook to 2030

4.2 Reference Growth Case Scenario Forecasts: Therapeutic Plasma Exchange Systems Market Size Outlook to 2030

4.3 High Growth Case Scenario Forecasts: Therapeutic Plasma Exchange Systems Market Size Outlook to 2030

 

5. Therapeutic Plasma Exchange Systems Market Segmentation- Outlook by Disease

5.1 Therapeutic Plasma Exchange Systems Market Share Analysis by Disease, 2023

5.2 Neurological Disorders Market Outlook to 2030

5.3 Cardiovascular Disorders Market Outlook to 2030

5.4 Hematology Disorders Market Outlook to 2030

5.5 Renal Disorders Market Outlook to 2030

5.6 Other Diseases Market Outlook to 2030

 

6. Therapeutic Plasma Exchange Systems Market Segmentation- Outlook by Product

6.1 Therapeutic Plasma Exchange Systems Market Share Analysis by Product, 2023

6.2 Apheresis Machine Market Outlook to 2030

6.3 Filters: Therapeutic Plasma Exchange Systems Market Outlook to 2030

6.4 Others

 

7. Therapeutic Plasma Exchange Systems Market Segmentation- Outlook by Application

7.1 Therapeutic Plasma Exchange Systems Market Share Analysis by Application, 2023

7.2 Hospitals: Therapeutic Plasma Exchange Systems Market Outlook to 2030

7.3 Ambulatory Surgical Centers: Therapeutic Plasma Exchange Systems Market Outlook to 2030

7.4 Others: Therapeutic Plasma Exchange Systems Market Outlook to 2030

 

8. North America Therapeutic Plasma Exchange Systems Market Outlook and Opportunities to 2030

8.1 Market Snapshot, 2023

8.2 North America Therapeutic Plasma Exchange Systems Market Growth Opportunities

8.2.1 North America Therapeutic Plasma Exchange Systems Market Outlook by Type, 2021 to 2030

8.2.2 North America Therapeutic Plasma Exchange Systems Market Outlook by Application, 2021 to 2030

8.2.3 North America Therapeutic Plasma Exchange Systems Market Outlook by Country, 2021 to 2030

8.3 United States Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

8.4 Canada Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

8.5 Mexico Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

 

9. Europe Therapeutic Plasma Exchange Systems Market Outlook and Opportunities to 2030

9.1 Market Snapshot, 2023

9.2 Europe Therapeutic Plasma Exchange Systems Market Growth Opportunities

9.2.1 Europe Therapeutic Plasma Exchange Systems Market Outlook by Type, 2021 to 2030

9.2.2 Europe Therapeutic Plasma Exchange Systems Market Outlook by Application, 2021 to 2030

9.2.3 Europe Therapeutic Plasma Exchange Systems Market Outlook by Country, 2021 to 2030

9.3 Germany Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

9.4 France Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

9.5 United Kingdom Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

9.6 Spain Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

9.7 Italy Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

9.8 Other Europe Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

 

10. Asia Pacific Therapeutic Plasma Exchange Systems Market Outlook and Opportunities to 2030

10.1 Market Snapshot, 2023

10.2 Asia Pacific Therapeutic Plasma Exchange Systems Market Growth Opportunities

10.2.1 Asia Pacific Therapeutic Plasma Exchange Systems Market Outlook by Type, 2021 to 2030

10.2.2 Asia Pacific Therapeutic Plasma Exchange Systems Market Outlook by Application, 2021 to 2030

10.2.3 Asia Pacific Therapeutic Plasma Exchange Systems Market Outlook by Country, 2021 to 2030

10.3 China Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

10.4 Japan Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

10.5 India Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

10.6 South Korea Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

10.7 Indonesia Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

10.8 Other Asia Pacific Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

 

11. South and Central America Therapeutic Plasma Exchange Systems Market Outlook and Opportunities to 2030

11.1 Market Snapshot, 2023

11.2 South and Central America Therapeutic Plasma Exchange Systems Market Growth Opportunities

11.2.1 South and Central America Therapeutic Plasma Exchange Systems Market Outlook by Type, 2021 to 2030

11.2.2 South and Central America Therapeutic Plasma Exchange Systems Market Outlook by Application, 2021 to 2030

11.2.3 South and Central America Therapeutic Plasma Exchange Systems Market Outlook by Country, 2021 to 2030

11.3 Brazil Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

11.4 Argentina Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

11.5 Other Latin America Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

 

12. Middle East and Africa Therapeutic Plasma Exchange Systems Market Outlook and Opportunities to 2030

12.1 Market Snapshot, 2023

12.2 Middle East and Africa Therapeutic Plasma Exchange Systems Market Growth Opportunities

12.2.1 Middle East and Africa Therapeutic Plasma Exchange Systems Market Outlook by Type, 2021 to 2030

12.2.2 Middle East and Africa Therapeutic Plasma Exchange Systems Market Outlook by Application, 2021 to 2030

12.2.3 Middle East and Africa Therapeutic Plasma Exchange Systems Market Outlook by Country, 2021 to 2030

12.3 Saudi Arabia Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

12.4 United Arab Emirates (the UAE) Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

12.5 Other Middle East Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

12.6 Egypt Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

12.7 South Africa Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

12.8 Other Africa Therapeutic Plasma Exchange Systems Market Outlook, 2021 to 2030

 

13. Profiles of major world Therapeutic Plasma Exchange Systems Companies

13.1 Baxter International Inc.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.2 Terumo Corporation

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.3 Asahi Kasei Corp.

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.4 B. Braun Melsngen AG

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.5 Fresenius-Kabi AG

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.6 Cerus Corp

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.7 Hemacare Corp

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

13.8 Terumo Corp

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

13.9 Kawasumi Laboratories

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

13.10 Haemonetics Corp

- Key Statistics

- Business Operations

- Products and Services Offered

- SWOT Analysis

- Financial Profile

- Financial Profile

14. Appendix

14.1 Publisher’s Expertise

14.2 List of Tables and Charts

14.3 List of Exhibits

14.4 Legal Disclaimer   

Sample Request